Saudi Pharma Climbs to Five-Year High on Covid Pact With CureVac
This article is for subscribers only.
Saudi Pharmaceutical Industries & Medical Appliances Corp. surged to the highest level in more than five years after signing a pact to supply CureVac NV’s coronavirus vaccine in the kingdom.
The shares closed 5.5% higher in Riyadh, taking the gain for the year to 58%. The benchmark Tadawul index rose 0.2%.